Definitive Contract HHSD200201793142C
Award Date
4/17/17
Potential Completion Date
4/16/22
Potential Value
$3.3M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chapel Hill, NC 27599, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
165
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,301,000 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) within the Department of Health and Human Services (HHS) to the University of New Mexico (UNM) to conduct Zika diagnostic and vector research. No set-aside was used. UNM, through its Health Sciences Center Financial Services Division, is performing this work, which includes testing the efficacy of encapsulated mandarin orange oil as a larvicide against mosquitoes in Brazil. UNM has...
The Centers for Disease Control and Prevention (CDC) awarded a $500,000 firm fixed price contract to The Johns Hopkins University to support Zika diagnostic and vector research efforts. Under the terms of the two-year agreement, set to run from July 2017 through June 2019, the prime contractor will deliver products and services to assist the CDC in addressing the Zika virus. No major subcontractors or set aside designations were indicated. This award advances the CDC's mission to monitor and...
This is a $149,883 firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, to the University of North Carolina at Chapel Hill (UNC) for the "Southern Tick-Associated Rash Illness" requirement. The contract does not have a set-aside designation. UNC, operating through its Office of Sponsored Research, is a public research university that has extensive experience providing scientific...
This federal contract award to the University of North Carolina at Chapel Hill (UNC-CH), Office of Sponsored Research, is for $142,000 in research services. The contract is a firm fixed price purchase order, with a completion date of August 31, 2016. It was awarded on July 31, 2015 by the Centers for Disease Control and Prevention (CDC), which is part of the U.S. Department of Health and Human Services. UNC-CH is a major public research university that receives substantial federal funding for...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price contract to Georgia State University Research Foundation Inc., a non-profit organization and foundation, for $1,530,000.00 to conduct Zika diagnostic and vector research. The contract has an April 16, 2022 completion date and was awarded on April 17, 2017. This contract is not designated as a set-aside. The Georgia State University Research Foundation Inc. has previously received...
This is a $494,681 Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution in Atlanta, Georgia, for "ENHANCED SURVEILLANCE - ZIKA." The contract does not have a set-aside designation. Emory University, through its Office of Sponsored Programs Division, is the prime contractor on this award. Universidad Autonoma De Yucatan (UADY), a state-controlled institution of higher learning in Mexico, is a...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to UPMC Center for Health Security, Inc., a non-profit organization and subsidiary of the University of Pittsburgh Medical Center (UPMC). The $803,792 firm fixed-price contract is for research on persuasive communication about risks from and responses to the Zika virus. The contract has an ultimate completion date of February 28, 2019 and was awarded on September 22, 2016. No set-aside was used for this...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $7,455,151.00 cost-plus-fixed-fee definitive contract to Vysnova Partners, LLC, a for-profit limited liability company, for a Zika Virus Longitudinal Study. The contract has a completion date of September 28, 2022 and does not have a set-aside designation. Vysnova Partners specializes in managing research on infectious diseases and has previously supported federal agencies like the Department of...
This is a $335,333,551.74 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Takeda Vaccines Inc. for the development of a Zika virus vaccine. The contract has a period of performance through September 30, 2024. It is a cost-plus-fixed-fee contract with no set-aside designation. The contract supports ASPR's Zika virus research and vaccine development initiatives. As the prime contractor, Takeda Vaccines Inc. is leading the effort and...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Definitive Contract to the University of Arizona, doing business as the Arizona Board of Regents, for $1,250,000.00 to conduct research on Zika diagnostic testing and vector control. The contract has no set-aside designation. The University of Arizona is a public research university and 1862 land grant institution located in Tucson, Arizona. As a state government entity, higher...